Stockreport

As part of the planned merger with DiamiR Biosciences, Aptorum Group will expand its board and management team with seasoned executives

Aptorum Group Limited - Class A Ordinary Shares  (APM) 
PDF NEW YORK, NY, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Aptorum Group Limited (NASDAQ: APM) ("Aptorum Group” or “Aptorum”), a clinical stage biopharmaceutical company dedicat [Read more]